Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 31 studies | 36% ± 15% | |
smooth muscle cell | 21 studies | 31% ± 12% | |
pericyte | 19 studies | 29% ± 12% | |
connective tissue cell | 15 studies | 43% ± 17% | |
myofibroblast cell | 12 studies | 44% ± 14% | |
mast cell | 9 studies | 21% ± 4% | |
basal cell | 8 studies | 28% ± 12% | |
mesothelial cell | 6 studies | 58% ± 18% | |
endothelial cell | 5 studies | 26% ± 12% | |
epithelial cell | 5 studies | 41% ± 18% | |
classical monocyte | 4 studies | 26% ± 8% | |
conventional dendritic cell | 4 studies | 33% ± 12% | |
hematopoietic stem cell | 4 studies | 25% ± 6% | |
adventitial cell | 4 studies | 26% ± 11% | |
ciliated cell | 4 studies | 31% ± 8% | |
non-classical monocyte | 3 studies | 22% ± 6% | |
abnormal cell | 3 studies | 31% ± 4% | |
myeloid cell | 3 studies | 23% ± 10% | |
type II pneumocyte | 3 studies | 25% ± 9% | |
astrocyte | 3 studies | 23% ± 9% | |
myoepithelial cell | 3 studies | 32% ± 10% | |
dendritic cell | 3 studies | 40% ± 17% | |
plasmacytoid dendritic cell | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 7881.35 | 180 / 180 | 100% | 109.69 | 429 / 430 |
thymus | 100% | 4789.53 | 653 / 653 | 100% | 155.35 | 603 / 605 |
uterus | 100% | 7315.40 | 170 / 170 | 98% | 106.99 | 449 / 459 |
lung | 100% | 3674.62 | 576 / 578 | 95% | 85.75 | 1099 / 1155 |
breast | 100% | 3764.01 | 459 / 459 | 93% | 71.48 | 1040 / 1118 |
kidney | 100% | 4173.73 | 89 / 89 | 92% | 80.34 | 833 / 901 |
skin | 100% | 4466.54 | 1808 / 1809 | 90% | 88.20 | 427 / 472 |
prostate | 100% | 5906.98 | 245 / 245 | 84% | 37.25 | 422 / 502 |
esophagus | 100% | 4392.53 | 1442 / 1445 | 83% | 50.21 | 151 / 183 |
bladder | 100% | 5995.62 | 21 / 21 | 72% | 56.86 | 363 / 504 |
adrenal gland | 100% | 5684.83 | 258 / 258 | 49% | 36.39 | 112 / 230 |
intestine | 97% | 4182.41 | 936 / 966 | 36% | 15.14 | 192 / 527 |
stomach | 76% | 2464.59 | 273 / 359 | 50% | 21.48 | 142 / 286 |
brain | 73% | 1064.97 | 1926 / 2642 | 38% | 29.37 | 268 / 705 |
tonsil | 0% | 0 | 0 / 0 | 100% | 67.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.79 | 1 / 1 |
blood vessel | 100% | 7257.07 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3723.93 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2513.42 | 240 / 241 | 0% | 0 | 0 / 0 |
pancreas | 7% | 70.17 | 22 / 328 | 85% | 54.43 | 151 / 178 |
heart | 85% | 1918.75 | 736 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 40.99 | 63 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 17.58 | 16 / 29 |
liver | 3% | 38.03 | 6 / 226 | 34% | 20.41 | 137 / 406 |
peripheral blood | 36% | 424.98 | 330 / 929 | 0% | 0 | 0 / 0 |
muscle | 16% | 174.06 | 128 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0044351 | Biological process | macropinocytosis |
GO_0060271 | Biological process | cilium assembly |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0090382 | Biological process | phagosome maturation |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0032418 | Biological process | lysosome localization |
GO_0019882 | Biological process | antigen processing and presentation |
GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005795 | Cellular component | Golgi stack |
GO_0005730 | Cellular component | nucleolus |
GO_0031985 | Cellular component | Golgi cisterna |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005814 | Cellular component | centriole |
GO_0005929 | Cellular component | cilium |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0031982 | Cellular component | vesicle |
GO_0030742 | Molecular function | GTP-dependent protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB34 |
Protein name | RAB34 protein RAB34, member RAS oncogene family Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats) Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah) RAB34, member RAS oncogene family (Ras-related GTP-binding protein RAB39) |
Synonyms | NARR RAB39 RAH |
Description | FUNCTION: Transport protein involved in the redistribution of lysosomes to the peri-Golgi region . Plays a role in the maturation of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis . Plays a role in the fusion of phagosomes with lysosomes . Involved in ciliogenesis . Acts also as a positive regulator of hedgehog signaling and regulates ciliary function (By similarity). . |
Accessions | ENST00000583538.5 ENST00000415040.6 [Q9BZG1-4] ENST00000625712.2 Q9BZG1 ENST00000636534.2 E7ES60 A0A1B0GWB1 ENST00000353676.9 H7C0Y7 ENST00000582934.1 C9JBG0 ENST00000422279.6 K7EIF2 ENST00000412625.5 Q96PJ7 ENST00000395245.9 [Q9BZG1-1] ENST00000419712.7 ENST00000395243.7 ENST00000453384.7 P0DI83 ENST00000636154.2 [P0DI83-1] ENST00000636772.1 ENST00000636513.1 ENST00000436730.7 [Q9BZG1-1] ENST00000301043.10 [Q9BZG1-1] C9JY26 ENST00000430132.6 J3QLC6 ENST00000580843.6 K7EJW7 A0A1B0GVI6 A0A1C7CYW6 V9GY61 A0A1B0GTQ2 Q6NXT3 ENST00000450529.5 [Q9BZG1-2] |